4 Pharma Majors Invest In ABCD Technologies

New Delhi : Drug majors Sun Pharma, Lupin, Cadila Healthcare and Torrent Pharma on Thursday said they have subscribed to partnership interest in healthcare services firm ABCD Technologies LLP which will be renamed as IndoHealth Services LLP. The four pharma majors are investing Rs 40 crore each in the target entity which is a recently incorporated limited liability partnership and has not commenced any business activities, they added.

Sun Pharma and Cadila Healthcare said one of the wholly owned Indian subsidiaries have subscribed to partnership interest in ABCD Technologies LLP.

The objective of the acquisition is to facilitate, enable and promote efficiency and good distribution practices, including digitising healthcare infrastructure in India, inter alia, in support of the National Digital Health Mission of Government of India, the regulatory filings said.

The nature of consideration is cash infusion as capital contribution and Sun Pharma, Lupin, Cadila Healthcare and Torrent Pharma are investing Rs 40 crore each in the target entity, they added.

While Sun Pharma and Cadila Healthcare said that Rs 40 crore is for 20 per cent share of profit/ loss in the target entity, Lupin and Torrent Pharma said Rs 40 crore is for up to 20 per cent share of profit/loss in the target entity.

  • Related Posts

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’